Study Evaluating Piperacillin-Tazobactam on Certain Bacteria in Hematology and Oncology Units

Clinical trial NCT00167999 · COMPLETED

Trial details

NCT number: NCT00167999
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Status: COMPLETED
Study type: OBSERVATIONAL

Gram-Positive Bacterial Infections Escherichia Coli Infections Klebsiella Infections

Start date: 2005-02-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.